Protocol · Home environment
Home light environment
B+
Headline grade
Daytime light exposure at circadian levels (outdoor light first)
Evidence type: Mixed evidence
The graded dose: Daytime: melanopic equivalent daylight illuminance (CIE S 026) of at least 250 lux at the eye across the day, reached outdoors in minutes (an overcast day runs roughly 1,000 to 10,000 lux outdoors; a lit office is 300 to 500 photopic lux and circadian-dim by comparison). Evening: at most 10 melanopic lux in the three hours before bed. Sleep: at most 1 melanopic lux. Targets are the 2022 international consensus recommendations (Brown et al., PLoS Biology), stated as expert consensus, not regulatory limits. Ordering: outdoors first, then window light, then products; a product's specification is its measured melanopic output at the seated eye position, not a colour temperature on a box. Frequency in the evidence: 7 sessions per week. Program length in the evidence: Daily pattern, continuous. The grade attaches to this dose; below it, the grade does not apply.
The caveat: The market sells this class as products (glasses, bulbs, systems). The graded record is mostly a pattern: bright days from the free source, dim evenings from a dimmer, and products judged by the light they actually deliver to the eye.
Build this protocol: see Home light environment assembled and graded, then adjust it to your goals.
Time cost
0 minutes / week
No session time; the record is a pattern of light levels at the eye across the day, from outdoor light and evening dimming.
Dollar cost
About $5 / month
Daylight and dimming cost nothing. Where products are used: dimmable warm-shifted evening lighting at ordinary household bulb prices; a dawn simulator at $30 to $150 one-time. This record's specification is a light level at the eye, not a product. (basis: device-amortized)
Every claim, graded
Each outcome this protocol is claimed to deliver carries its own grade and its own kind of evidence. A strong secondary outcome never launders a weak popular claim: the popular claim prints at its own grade, next to the headline.
Outcomes at a glance
Daytime light exposure at circadian levels (outdoor light first)
Improves sleep quality, mood, and alertness from daytime light exposure (independent of the seasonal depression protocol)
Reduces evening light exposure at the eye (dimming toward the consensus evening target)
Blue-blocking glasses improve eye strain, sleep, and retinal health (the claim as sold)
Bar length is the outcome's evidence grade on the house scale: A is 4.0 points, B is 3.0, C is 2.0, D is 1.0. The table below carries the evidence type and what the data show for each row.
| Claim | Grade | Evidence | What the data show |
|---|---|---|---|
| Daytime light exposure at circadian levels (outdoor light first) | B+ | mixedMixed evidence | The exposure gap is the finding: indoor daytime light runs one to two orders of magnitude below outdoor light, and the circadian system entrains primarily to the daytime signal. Outdoor light delivers circadian-effective levels within minutes even under cloud, which no indoor product at normal room distances matches; the exposure itself is measured and not in dispute, which is what B+ grades here. Health outcomes from daytime exposure are graded separately below and sit lower.Brown TM et al. Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults. PLoS Biology, 2022 (melanopic EDI targets: at least 250 lux daytime, at most 10 lux in the three hours before bed, at most 1 lux during sleep).; CIE S 026 (melanopic equivalent daylight illuminance), the measurement standard this record's doseSpec uses. |
| Improves sleep quality, mood, and alertness from daytime light exposure (independent of the seasonal depression protocol) | C+ | mixedMixed evidence | Observational cohorts and small trials point consistently in the same direction as the seasonal literature the live bright light therapy record grades, but as a standalone home-environment claim the base is thinner: grade C+. Longevity or mortality claims from light exposure have no direct evidence and grade D wherever they appear.Brown TM et al., PLoS Biology, 2022 (consensus review of the daytime light, sleep, and alertness literature). |
| Reduces evening light exposure at the eye (dimming toward the consensus evening target) | B | mixedMixed evidence | Evening light, especially short-wavelength-enriched light at ordinary room levels, suppresses and delays melatonin in controlled studies at melanopic levels common in homes; bringing the evening level down is achievable and measurable at the eye (B for the exposure change). Controlled studies of evening reduction show sleep timing and continuity benefits at small scale (C+). Metabolic and cancer claims ride on shift-work epidemiology, which classifies a work pattern, not home lighting, and do not transfer as outcome grades (D+).Brown TM et al., PLoS Biology, 2022; IARC Monographs classification of night shift work (Group 2A), cited to mark what it does not cover. |
| Blue-blocking glasses improve eye strain, sleep, and retinal health (the claim as sold) | D | meta-analysis | The claim was checked against the primary synthesis: the Cochrane review of blue-light filtering lenses (Singh et al., 2023; 17 trials) found they probably make little or no difference to eye strain, with sleep effects uncertain and no demonstrated retinal benefit, and the American Academy of Ophthalmology does not recommend them for eye strain, whose driver is reduced blink rate and focus demand rather than blue light dose at screen levels. Eye strain and retinal protection grade D. The narrower evening sleep claim has a plausible melanopic route and small mixed trials (C-), and the stronger lever is the one in the outcome above: dimming the light itself.Singh S et al. Blue-light filtering spectacle lenses for visual performance, sleep, and macular health. Cochrane Database of Systematic Reviews, 2023.; American Academy of Ophthalmology guidance on blue-light filtering lenses and digital eye strain. |
Dose and response
The circadian system reads light level at the eye on a logarithmic scale, so the practical steps are orders of magnitude, not percentages: outdoor light exceeds indoor light by one to two orders, and evening reduction works by bringing the eye's level down toward the consensus evening target. Duration trades against level: a brighter morning exposure needs fewer minutes.
Equipment that can deliver this dose: Home device. Most of this record needs no equipment. Light therapy boxes belong to the live bright light therapy protocol and are not respecified here.
Harms and cautions
Harms live in this ledger, not inside the grade: the grade is evidence for the claimed outcomes in the studied population.
Medication interactions
No medication classes are flagged in this graded record.
Goal conflicts and timing
No goal conflicts in this record.
Daily: outdoor light early in the day where possible; evening dimming in the last three hours before bed.
Population exclusions and other cautions
Evening light reduction taken to extremes creates ordinary household hazards (stairs, night driving preparation) that common sense governs caution
The graded target is at most 10 melanopic lux in the three hours before bed, not darkness across the evening.
Source: Research environment-evidence pack: light (2026-11-12)
Dawn simulation can advance waking in people who must not wake earlier caution
A dawn simulator is an optional product inside this record’s cost range, not its specification.
Source: Research environment-evidence pack: light (2026-11-12)
Can you measure it yourself?
No self-experiment is offered for this record's headline outcomes. Environment class draft under research/environment-rubric.md. Source pack: research/environment-evidence/light-evidence-pack.md (2026-11-12). This record does NOT regrade bright light therapy or red light therapy; both live protocols stand as graded and are cross-linked, not restated. goals derivation: no outcome reaches the B- serving floor, so goals is empty with the derivation recorded in goalsNote.
Goals served
None at the serving floor
Derived from outcomes grading B- or better, never hand-assigned.
Experience gate
beginner and up (gated for safety)
Applicability
broad
Applies broadly, across goals and populations.
Grades are research summaries, not medical advice. Decisions about your own stack belong with your clinician.
Longevity Lab Report
Protocol news. Graded when it happens.
The grades on this page stay free. The email is the week's longevity and biohacking news in plain English: expert moves, what is working, and new supplements and peptides, each story linked to the grades on this site.
Frequently asked questions
What grade does Home light environment get?
At the studied dose (Daytime: melanopic equivalent daylight illuminance (CIE S 026) of at least 250 lux at the eye across the day, reached outdoors in minutes (an overcast day runs roughly 1,000 to 10,000 lux outdoors; a lit office is 300 to 500 photopic lux and circadian-dim by comparison). Evening: at most 10 melanopic lux in the three hours before bed. Sleep: at most 1 melanopic lux. Targets are the 2022 international consensus recommendations (Brown et al., PLoS Biology), stated as expert consensus, not regulatory limits. Ordering: outdoors first, then window light, then products; a product's specification is its measured melanopic output at the seated eye position, not a colour temperature on a box.), Home light environment grades B+ for daytime light exposure at circadian levels (outdoor light first), on mixed evidence. The grade attaches to that dose; below it, the grade does not apply.
How much time does Home light environment take each week?
At the graded dose: No session time; the record is a pattern of light levels at the eye across the day, from outdoor light and evening dimming. Dollar cost: Daylight and dimming cost nothing. Where products are used: dimmable warm-shifted evening lighting at ordinary household bulb prices; a dawn simulator at $30 to $150 one-time. This record's specification is a light level at the eye, not a product..
Sources
- Brown TM et al., PLoS Biology, 2022. (2022)
- CIE S 026.
- Singh S et al., Cochrane Database of Systematic Reviews, 2023. (2023)
Changelog
Last reviewed November 13, 2026
- 2026-11-13|Graded draft filed (Research): the home light class frame graded over the two live light protocols, which it does not regrade. Outdoor-first ordering throughout. Pending Growth integration.